Cluster-Based CKD Management
The findings support managing concurrent metabolic abnormalities as clusters rather than relying only on single-factor strategies. The trajectories should be interpreted as real-world metabolic control patterns shaped by disease biology an…
1 sources - 4 claims
The findings support managing concurrent metabolic abnormalities as clusters rather than relying only on single-factor strategies. The trajectories should be interpreted as real-world metabolic control patterns shaped by disease biology and treatment effects. Longitudinal monitoring of SBP, fasting glucose, and LDL cholesterol may help stratify risk among patients with advanced CKD. The study supports routine repeated assessment of metabolic risk profiles in CKD care.